Telmisartan + Amlodipine + Bisoprolol Tablet Franchise in Ahmedabad

Cardiac Care Tablet Supplier in Mumbai

Hypertension Medicine Distributor in Delhi

Cardiology Pharma Franchise in Bangalore

Telmisartan Amlodipine Tablet Stockist in Hyderabad
Cardiac Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /telmisartan-40mg-amlodipine-5mg-bisoprolol-5mg-tablet

Telbolife AB 5 Tablet

Composition : Telmisartan (40mg) + Amlodipine (5mg) + Bisoprolol (5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Telbolife AB 5 Tablet contains Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 5mg, a triple-action therapy for hypertension and comprehensive cardiac support. Telmisartan reduces vascular resistance by blocking angiotensin receptors, Amlodipine relaxes blood vessels for improved circulation, and Bisoprolol helps regulate heart rate, delivering effective blood pressure control and heart protection.

This combination offers superior clinical efficacy and is highly trusted by prescribers, ensuring consistent demand. Patients experience improved cardiovascular health, better blood pressure control, and enhanced compliance due to its all-in-one therapy approach.

For franchise partners, Telbolife AB 5 Tablet is a high-demand cardiac care product with excellent market acceptance. Its proven therapeutic performance and prescriber confidence make it a profitable addition to any cardiovascular portfolio, helping expand business opportunities and strengthen client loyalty.

With its comprehensive heart health benefits, Telbolife AB 5 Tablet supports sustainable sales growth and positions partners to serve the growing hypertension and cardiology market effectively.

Read More

About the Product

Telbolife AB 5 Tablet contains Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 5mg, a triple-action therapy for hypertension and comprehensive cardiac support. Telmisartan reduces vascular resistance by blocking angiotensin receptors, Amlodipine relaxes blood vessels for improved circulation, and Bisoprolol helps regulate heart rate, delivering effective blood pressure control and heart protection.

This combination offers superior clinical efficacy and is highly trusted by prescribers, ensuring consistent demand. Patients experience improved cardiovascular health, better blood pressure control, and enhanced compliance due to its all-in-one therapy approach.

For franchise partners, Telbolife AB 5 Tablet is a high-demand cardiac care product with excellent market acceptance. Its proven therapeutic performance and prescriber confidence make it a profitable addition to any cardiovascular portfolio, helping expand business opportunities and strengthen client loyalty.

With its comprehensive heart health benefits, Telbolife AB 5 Tablet supports sustainable sales growth and positions partners to serve the growing hypertension and cardiology market effectively.

Common side effects may include dizziness, fatigue, headache, palpitations, flushing, and mild swelling of the ankles. Less frequent adverse effects include hypotension, bradycardia, gastrointestinal discomfort, or sleep disturbances. Any severe or persistent symptoms should be reported promptly to a healthcare professional.

Telbolife AB 5 Tablet is indicated for the treatment of essential hypertension in adults, particularly in patients who need combination therapy for optimal blood pressure control. It is also suitable for patients with additional cardiovascular risk factors such as coronary artery disease, diabetes, or kidney disease.

Telbolife AB 5 Tablet should be taken strictly as prescribed. Blood pressure, heart rate, and kidney function should be monitored regularly. Do not stop therapy abruptly, as this may exacerbate cardiovascular conditions. Patients should inform their doctor about other medications or health conditions before starting this tablet.

Store Telbolife AB 5 Tablet in a cool, dry place, away from sunlight and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation